IN2015DN00202A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00202A
IN2015DN00202A IN202DEN2015A IN2015DN00202A IN 2015DN00202 A IN2015DN00202 A IN 2015DN00202A IN 202DEN2015 A IN202DEN2015 A IN 202DEN2015A IN 2015DN00202 A IN2015DN00202 A IN 2015DN00202A
Authority
IN
India
Prior art keywords
mula
inhibitors
compounds
formula
neutrophil elastase
Prior art date
Application number
Other languages
English (en)
Inventor
Carmelida Capaldi
Robert Andrew Heald
Nicholas Charles Ray
Jonathan Mark Sutton
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IN2015DN00202A publication Critical patent/IN2015DN00202A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN202DEN2015 2012-07-12 2013-07-10 IN2015DN00202A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12176079 2012-07-12
EP13158756 2013-03-12
PCT/EP2013/064603 WO2014009425A1 (fr) 2012-07-12 2013-07-10 Inhibition d'enzymes

Publications (1)

Publication Number Publication Date
IN2015DN00202A true IN2015DN00202A (fr) 2015-06-12

Family

ID=48953361

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202DEN2015 IN2015DN00202A (fr) 2012-07-12 2013-07-10

Country Status (11)

Country Link
US (1) US9199984B2 (fr)
EP (1) EP2872509B1 (fr)
KR (1) KR20150031318A (fr)
CN (1) CN104428300B (fr)
AR (1) AR091737A1 (fr)
BR (1) BR112015000507A2 (fr)
CA (1) CA2878792A1 (fr)
HK (1) HK1207078A1 (fr)
IN (1) IN2015DN00202A (fr)
RU (1) RU2638537C2 (fr)
WO (1) WO2014009425A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105873933A (zh) 2013-12-16 2016-08-17 奇斯药制品公司 作为人中性白细胞弹性蛋白酶抑制剂的四氢三唑并嘧啶衍生物
US9487528B2 (en) 2014-06-09 2016-11-08 Chiesi Farmaceutici S.P.A. Compounds
US9657015B2 (en) 2014-07-31 2017-05-23 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9475779B2 (en) 2014-07-31 2016-10-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9440930B2 (en) 2014-07-31 2016-09-13 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9409870B2 (en) 2014-12-15 2016-08-09 Chiesi Farmaceutici S.P.A. Compounds
CN109311850B (zh) 2016-05-31 2021-11-19 奇斯药制品公司 作为人嗜中性粒细胞弹性蛋白酶抑制剂的咪唑酮化合物
AR108608A1 (es) 2016-05-31 2018-09-05 Chiesi Farm Spa Derivados de pirazolil carbonilo inhibidores de ahr
WO2017207433A1 (fr) * 2016-05-31 2017-12-07 Chiesi Farmaceutici S.P.A. Composés hétérocycliques destinés à être utilisés dans le traitement d'une maladie dans laquelle est impliquée l'élastase neutrophile humaine (hne)
AU2018223313B2 (en) 2017-02-27 2023-02-23 Géza BÁLINT Smart device with a display that enables simultaneous multi-functional handling of the displayed information and/or data
TW202118391A (zh) 2019-07-23 2021-05-16 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基三唑化合物(二)
TW202118754A (zh) 2019-07-23 2021-05-16 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基三唑化合物(一)
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ 4 リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
MX2022004366A (es) 2019-10-09 2022-05-06 Bayer Ag Nuevos compuestos de heteroarilo-triazol como pesticidas.
UY38911A (es) 2019-10-09 2021-05-31 Bayer Ag Compuestos de heteroarilo-triazol como pesticidas, formulaciones, usos y métodos de uso de los mismos
US20230117470A1 (en) * 2019-11-01 2023-04-20 Bristol-Myers Squibb Company Substituted pyrazole compounds as toll receptor inhibitors
TW202134226A (zh) 2019-11-18 2021-09-16 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基-三唑化合物
FI4106757T3 (fi) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Neutrofiilien elastaasin inhibiittori alvelestaattia sisältäviä menetelmiä alfa-1-antitrypsiinipuutoksen välittämän hengityselintaudin hoitamiseksi
CN113480486B (zh) * 2021-07-30 2022-05-24 赣南师范大学 一种3-胺基-1,2,4-三唑类衍生物及其制备方法和应用
CA3234399A1 (fr) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Inhibiteurs de l'elastase neutrophile utilises dans le traitement de la fibrose

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259504A (en) 1979-08-27 1981-03-31 American Cyanamid Company Substituted 1H-1,2,4-triazoles
US4451471A (en) 1981-03-18 1984-05-29 Ciba-Geigy Corporation Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same
US4576958A (en) 1984-01-23 1986-03-18 E. I. Du Pont De Nemours And Company Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
ES2184633B1 (es) 2001-08-07 2004-08-01 J. URIACH & CIA, S.A. Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
US6693116B2 (en) * 2001-10-08 2004-02-17 Hoffmann-La Roche Inc. Adenosine receptor ligands
US7524860B2 (en) 2004-10-07 2009-04-28 Pfizer Inc. Antibacterial agents
US7902374B2 (en) 2005-05-06 2011-03-08 Universal Display Corporation Stability OLED materials and devices
US20080125587A1 (en) 2006-05-25 2008-05-29 Chimmanamada Dinesh U Synthesis of triazole compounds that modulate HSP90 activity
WO2009061271A1 (fr) * 2007-11-06 2009-05-14 Astrazeneca Ab Certains dérivés de 2-pyrazinone et leur utilisation comme inhibiteurs d'élastase des neutrophiles
PE20091953A1 (es) 2008-05-08 2010-01-09 Du Pont Azoles sustituidos como fungicidas
US8338604B2 (en) * 2008-06-20 2012-12-25 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
CN102131806A (zh) * 2008-06-20 2011-07-20 百时美施贵宝公司 用作激酶抑制剂的三唑并吡啶化合物
DE102009004197A1 (de) * 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung
CA2773618A1 (fr) * 2009-10-02 2011-04-07 Astrazeneca Ab Composes 2-pyridones utilises comme inhibiteurs d'elastase de neutrophile

Also Published As

Publication number Publication date
EP2872509A1 (fr) 2015-05-20
CN104428300B (zh) 2016-11-09
RU2015104644A (ru) 2016-08-27
BR112015000507A2 (pt) 2017-06-27
CN104428300A (zh) 2015-03-18
HK1207078A1 (en) 2016-01-22
WO2014009425A1 (fr) 2014-01-16
US9199984B2 (en) 2015-12-01
EP2872509B1 (fr) 2016-09-14
RU2638537C2 (ru) 2017-12-14
KR20150031318A (ko) 2015-03-23
CA2878792A1 (fr) 2014-01-16
US20140018345A1 (en) 2014-01-16
AR091737A1 (es) 2015-02-25

Similar Documents

Publication Publication Date Title
IN2015DN00202A (fr)
UY34092A (es) Nuevos compuestos como inhibidores de jak
AU2013291345B2 (en) Composition for controlling plant disease and application therefor
UY34051A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
CR20140024A (es) Compuestos inhibidores de metaloenzimas
PH12014502169A1 (en) N-cyclylamides as nematicides
HRP20180139T1 (hr) Supstituirani piridopirazini kao novi syk-inhibitori
UY34145A (es) Compuestos inhibidores de metaloenzimas
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
UY33958A (es) Inhibidores de la glucosilceramida sintasa
MY164776A (en) Heterocyclic compound
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
UY33930A (es) Inhibidores novedosos de quinasas
UY34300A (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE LA QUINASA c-Kit
UY33929A (es) Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas
UY34523A (es) Derivados de betulina
CR20130539A (es) Triazolopiridinas
IN2015DN01061A (fr)
IN2015DN00598A (fr)
IN2014MN01637A (fr)
NZ711192A (en) Process for making benzoxazepin compounds
UY34329A (es) Compuestos de triazolopiridina
MX366983B (es) Derivados de 1,5-naftiridina e inhibidores de cinasa de cremallallera de leucina embrionica materna que los contienen.
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
IN2015DN00950A (fr)